Immunoglobulin G
Dupilumab for atopic dermatitis linked to lower antibody levels after COVID-19 infection
Patients taking dupilumab for atopic dermatitis who developed COVID-19 had lower levels of antibodies and milder symptoms than patients on other treatments, according to a study published in Annals of Allergy, Asthma & Immunology.
Patients with multiple myeloma show ‘suboptimal’ responses to COVID-19 vaccination
Patients with multiple myeloma mounted suboptimal and variable antibody responses to the messenger RNA COVID-19 vaccines, according to study results published in Cancer Cell.
Patients with cancer achieve response to messenger RNA COVID-19 vaccine
A high percentage of patients undergoing treatment for cancer achieved a sufficient antibody response to the BNT162b2 messenger RNA COVID-19 vaccine, according to study results published in JAMA Oncology.
Study reveals how patients on hemodialysis respond to Pfizer’s COVID-19 vaccine
Research in Israel showed that while patients on maintenance hemodialysis had a “substantial” antibody response to the COVID-19 vaccine from Pfizer and BioNTech, the response was lower than that seen for those without kidney disease.
Individuals with psychosis more likely to have certain antibodies
Measles tests: What PCPs need to know
Although the United States appears to have avoided losing its nearly 20-year status as a measle-free nation, there have been at least 1,243 cases of measles from 31 states reported to the CDC thus far in 2019 — more than any year since 1992.